Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma - Wikidata - wikimedia - TriplyDB

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma

http://www.wikidata.org/entity/Q36785144

about

Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt Signalling Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications.Molecular Testing of Brain Tumor.Genomic profile of human meningioma cell lines.PET Imaging in Patients with Meningioma - Report of the RANO/PET Group.Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.Genomic landscape of high-grade meningiomas.SMARCE1 mutation screening in classification of clear cell meningiomas.Genetic landscape of meningioma.The Emerging Role of TRAF7 in Tumor Development.SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas.BAP1 mutations in high-grade meningioma: implications for patient care.Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines.Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas.Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling.MiR-34a-3p alters proliferation and apoptosis of meningioma cells in vitro and is directly targeting SMAD4, FRAT1 and BCL2 Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.Progestin-associated shift of meningioma mutational landscape.Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.Clinicopathological and molecular characteristics of pediatric meningiomas.Systemic therapy for recurrent meningioma.Report of a Novel Case of Anaplastic Olfactory Groove Meningioma and Its Methylation Subtype.Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.SMO mutant olfactory groove meningiomas-the next in line for targeted therapy.In situ characterization of stem cells-like biomarkers in meningiomas.Nuclear Klf4 accumulation is associated with cetuximab drug-resistance and predicts poor prognosis of nasopharyngeal carcinoma.An overview of meningiomas Genetic Alterations of TRAF Proteins in Human Cancers Brain Tumours Emerging Medical Treatments for Meningioma in the Molecular Era

P2860

Q26739662-5861B460-701B-4461-8B4B-C279C7C9AF5A Q26741529-527A9098-3A67-4A53-AF1B-0BBA2C43C44A Q33729693-9F23F78D-2C89-4F0B-9A2A-CA1C4C3D3BE6 Q33731952-28053ACE-0C79-4E9B-B5C5-5A5C5D75CDE8 Q34682187-5346B376-1AE7-4167-9889-3218F21FD10B Q37420954-0B4C6CF9-1B61-4B13-9277-0016A95D662B Q38676440-999FEEDF-C4F7-4F54-B3A6-180E71607A09 Q38790141-8750A4DE-03EF-4D93-98D6-88863CE6F658 Q38953562-006F38B8-7044-417B-BA71-07087C80693A Q38997320-1A8CF7DB-7FA6-4F12-8649-4A289B578526 Q39023691-40BDD26C-56EF-4B27-8FC0-4DF2F3E72C13 Q39290955-81A743D7-F591-4BD0-B36B-FF97A574A676 Q41085366-7CA05947-B7C0-433B-975F-EA565FB01941 Q41243504-BB4B9342-44E7-4FEF-8295-05F181E4C259 Q41705181-E5FD26E4-4ACA-48B7-9C91-F6A5184E81F3 Q42291680-A4DED88C-06AD-4B2E-930B-7CB674207C86 Q46129842-AB10F266-7869-4534-AAF7-85B2F8CC0029 Q47569053-6F85EA61-24EA-4207-A27F-796E765FDCD0 Q48302173-ED812F53-DDCD-4179-B8AE-8D77F91D1F18 Q48355463-B213D964-A556-4C5F-8AA6-C027358F5302 Q48787594-B565393F-2D0E-4045-9BBF-2F784EB9B786 Q50089857-9008C957-E681-4C9C-AEE6-2C51ECE9ED5D Q50664835-2476B162-C8E6-46D0-9D26-BA96F65C4DA6 Q53971614-E7E55234-2884-4E79-9295-1BF480C47F64 Q54983777-C1BD068E-C4A8-4A9F-B87E-392344CE0803 Q55518643-B7F2BA49-D6DC-446D-B9D6-FB508C5FFB5E Q57163869-BFF67497-09BE-4A15-9F73-8E4A9DBB3BC8 Q57191736-A066490D-F266-4CB5-8A9E-C0C5042BA79C Q58491122-DE5BA558-DA82-4315-BCA9-952CDC165732 Q58798211-2795CFAF-C810-4FA5-BC4A-D24BF862110F

P2860

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma

http://www.wikidata.org/entity/Q36785144

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma

@en

type

label

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma

@en

prefLabel

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma

@en

P1433

Q36785144-2DA5917B-F83B-4E7F-88DF-FB828E98DFC0

P1476

Q36785144-10DAAB1C-9349-41B8-AA3A-EFA6A8FA9B66

P2093

Q36785144-01E8C2A3-605C-402A-B768-87B869E7298F

Q36785144-1CBEF8D7-4F91-44EB-85D7-87B0CE7E334C

Q36785144-2864D110-1A9C-419F-9CBD-A6DB7A452848

Q36785144-29CB484F-F436-4055-9F36-F3EE171D25B0

Q36785144-34F9D8B4-044C-42B6-B482-B9B40FC14173

Q36785144-3A8F4500-9E8B-40B5-822C-031E58CB066D

Q36785144-3CBF5C5D-DE95-40E7-BB7A-2ADAD0E58038

Q36785144-5688C6D9-F688-449D-BF4C-757951441113

Q36785144-583D4868-4C04-4C52-98C4-042931A1C7F4

Q36785144-639BC79C-B442-4808-B22F-A5DA02E19850

P2860

Q36785144-07E8347C-99DF-4D97-8124-191AFEEFA805

Q36785144-08EAB1B8-2794-404F-965B-8AE959F247B6

Q36785144-09160485-9E2A-40AB-815A-02B646B205FE

Q36785144-0AEF5292-9787-4F27-8DC7-4CC8A12B2678

Q36785144-0DE8FE38-C830-4CE6-A417-57B61CB5D20D

Q36785144-0E58848A-35F6-4D82-A599-D221D88AD7D5

Q36785144-105C981C-6963-4808-A23C-036AE3C52B8D

Q36785144-109C5EBE-A2A0-4218-829D-8AF29E738863

Q36785144-2061213F-5F0F-40BA-88C1-4BCE6D66C000

Q36785144-213A2F27-E6F9-41F5-81AD-19A602305811

P304

Q36785144-2D05249E-DD7E-4E10-9ED5-18E7AA59F929

P31

Q36785144-2C97A97D-7372-4E50-BFF9-218031EAA657

P356

Q36785144-41E3121B-6953-4E28-8C61-37672CB0105E

P433

Q36785144-0F108AC5-13DF-4670-8C46-0922557CA509

P478

Q36785144-EB7D1C0D-E83F-4A84-8A38-8FD0FC8AC546

P50

Q36785144-130E34D0-33F8-4537-AD10-7F28A5175241

Q36785144-573C08D3-A4BE-47E3-A271-806C001596CC

Q36785144-80060159-10CC-4F33-8EBA-C7A33D21B05E

P577

Q36785144-6C548899-E56E-4C22-8D92-508399CDB3BB

P5875

Q36785144-49E9CC82-0D85-4881-9ABB-C51BE880AF7A

P698

Q36785144-CEDB71B1-B067-4ACD-B776-64252EFCF3E0

P932

Q36785144-49FE59F6-7F9E-4D42-AD35-46959035EE18

P356

P1433

P1476

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma

@en

P2093

Aaron R Thorner

http://www.w3.org/2001/XMLSchema#string

Ayal A Aizer

http://www.w3.org/2001/XMLSchema#string

Azra H Ligon

http://www.w3.org/2001/XMLSchema#string

Brian M Alexander

http://www.w3.org/2001/XMLSchema#string

David A Reardon

http://www.w3.org/2001/XMLSchema#string

Dora Dias-Santagata

http://www.w3.org/2001/XMLSchema#string

Ian F Dunn

http://www.w3.org/2001/XMLSchema#string

Keith L Ligon

http://www.w3.org/2001/XMLSchema#string

Malak Abedalthagafi

http://www.w3.org/2001/XMLSchema#string

Marc L Listewnik

http://www.w3.org/2001/XMLSchema#string

P2860

The 2007 WHO classification of tumours of the central nervous system

ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma

Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.

Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.

Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.

Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.

DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues.

EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas

Epidemiology and etiology of meningioma

P304

649-655

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOV316

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Parker H Merrill

Priscilla K Brastianos

P577

2016-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292346148

http://www.w3.org/2001/XMLSchema#string

P698

26826201

http://www.w3.org/2001/XMLSchema#string

P932

4827048

http://www.w3.org/2001/XMLSchema#string